Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations
<p>Abstract</p> <p>Malignant Mesothelioma is an uncommon and very aggressive tumor that accounts for 1% of all the deaths secondary to malignancy in humans. Interestingly, this neoplasm has been occasionally described in companion animals as well. Aim of this study was the preclini...
Main Authors: | Citro Gennaro, Caruso Giovanni, Scarabello Alessandra, Crispi Stefania, Spugnini Enrico P, Baldi Alfonso |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-05-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | http://www.jeccr.com/content/27/1/6 |
Similar Items
-
Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.
by: Alfonso Baldi, et al.
Published: (2011-01-01) -
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
by: Sacchi Ada, et al.
Published: (2008-05-01) -
Retraction Note: Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
by: Alessandra Verdina, et al.
Published: (2022-12-01) -
Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans
by: Baldi Alfonso, et al.
Published: (2009-08-01) -
Patterns of tumor response in canine and feline cancer patients treated with electrochemotherapy: preclinical data for the standardization of this treatment in pets and humans
by: Bonetto Francesco, et al.
Published: (2007-10-01)